Loading...
Putting the brakes on BTLA in T cell–mediated cancer immunotherapy
Attenuating coinhibitory molecules for the treatment of cancer is gaining a great deal of attention as a strategy for immunotherapy. The B and T lymphocyte attenuator (BTLA, CD272) is a novel coinhibitory molecule structurally and functionally related to CTLA-4 and PD-1. A study in this issue of the...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2798708/ https://ncbi.nlm.nih.gov/pubmed/20038807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI41811 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|